Insider sales: Katie Colendich sells ASAN shares totaling $606K (ASAN)

Rhea-AI Filing Summary

Katie Colendich reported sales of Common Stock of ASAN. The filings show a sale of 18,624 shares on 12/22/2025 for $266,501.99 and a sale of 25,328 shares on 12/24/2025 for $339,336.95. The form lists planned securities entries including 618 shares from an Employee Stock Purchase Plan (09/15/2025) and 6,686 restricted shares (12/20/2025).

Insights

Equity Capital Markets Analyst

Insider reported routine secondary-market dispositions, not an issuance.

The filings record two open‑market sales by Katie Colendich: $266,501.99 for 18,624 shares on 12/22/2025 and $339,336.95 for 25,328 shares on 12/24/2025.

These entries represent reported dispositions; cash‑flow recipients are the selling holder(s). Subsequent filings may clarify whether sales were pursuant to a plan, but timing and plan details are not specified in the provided excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7304	54217.31	157538321	03/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Employee Stock Purchase Plan	Issuer			618	09/15/2025	Cash
Common	12/20/2025	Restricted Stock	Issuer			6686	12/20/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KATIE COLENDICH 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	12/24/2025	25328	339336.95
KATIE COLENDICH 633 Folsom Street, Suite 100 San Francisco CA 94107	Common	12/22/2025	18624	266501.99

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What transactions did Katie Colendich report in the ASAN Form 144?

She reported two sales: 18,624 shares on 12/22/2025 for $266,501.99 and 25,328 shares on 12/24/2025 for $339,336.95. The entries are recorded as dispositions of Common Stock.

Does the Form 144 show any planned issuances or awards for ASAN?

The excerpt lists planned securities entries: 618 shares tied to an Employee Stock Purchase Plan (09/15/2025) and 6,686 restricted shares (12/20/2025). These appear as listed securities in the filing.

Who receives the proceeds from the sales reported on Form 144?

Proceeds are shown as amounts tied to the selling holder: $266,501.99 and $339,336.95. The filing attributes the proceeds to the selling holder(s); issuer cash treatment is not stated in the excerpt.

Are these Form 144 sales indicative of company stock issuance or dilution?

No. The entries record reported sales by a holder, not a new issuance. The filing does not register new shares for issuance; listed plan/reserved figures are separate and do not imply dilution within this excerpt.